| |
| |
|
| Insider
Information: |
Ligand Pharmaceuticals Inc |
| Relationship: |
10% Owner |
| City: |
Syossett |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
32,863,820 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$445,489,643 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
32,863,820 |
|
|
| Total
Value |
$445,489,643 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -45.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ligand Pharmaceuticals Inc |
LGND |
Director |
2008-08-04 |
10,000 |
2008-08-04 |
0 |
Premium* |
|
|
Viking Therapeutics, Inc. |
VKTX |
10% Owner |
2020-08-26 |
5,819,383 |
|
0 |
Premium* |
|
|
Pfenex Inc. |
PFNX |
10% Owner |
2020-10-01 |
27,034,437 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PFNX |
Pfenex Inc. |
10% Owner |
– – • |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
27,034,437 |
|
- |
|
| VKTX |
Viking Therapeutics, Inc. |
10% Owner |
– – • |
2020-08-26 |
4/A |
S |
$8.11 |
$1,205,660 |
D/D |
(148,700) |
5,819,383 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
10% Owner |
– – • |
2020-08-26 |
4 |
S |
$8.11 |
$766,109 |
D/D |
(94,488) |
5,819,383 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
10% Owner |
– – • |
2020-08-25 |
4 |
S |
$8.02 |
$561,575 |
D/D |
(70,000) |
5,968,083 |
0 |
% |
|
| VKTX |
Viking Therapeutics, Inc. |
10% Owner |
– – • |
2018-09-25 |
4 |
S |
$19.15 |
$5,034,250 |
D/D |
(262,881) |
6,038,083 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
10% Owner |
– – • |
2016-04-13 |
4 |
OE |
$1.25 |
$1,200,000 |
D/D |
960,000 |
6,300,964 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
10% Owner |
– – • |
2016-04-13 |
4 |
A |
$0.00 |
$0 |
D/D |
560,000 |
5,340,964 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
10% Owner |
– – • |
2015-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
228,105 |
4,780,964 |
0 |
- |
|
| VKTX |
Viking Therapeutics, Inc. |
10% Owner |
– – • |
2015-05-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
4,552,859 |
|
- |
|
| LGND |
Ligand Pharmaceuticals In... |
Director |
– • – |
2008-08-04 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
